secwatch.observer — SEC 8-K summary
======================================

Issuer:     HENRY SCHEIN INC (HSIC)
CIK:        0001000228
Form:       8-K
Filed at:   2025-05-02T23:59:59+00:00
Accession:  0001193125-25-111677
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Henry Schein appoints KKR partner Max Lin to board; removes KKR voting commitment
--------------------------------------------------------------------------------

- Max Lin, a KKR partner and head of Americas Health Care Private Equity, appointed to board effective May 2, 2025.
- Board size increased to 15 directors; Lin will serve on Nominating/Governance and Strategic Advisory committees.
- Regulatory conditions (HSR, Sweden/Italy approvals) for Lin's appointment satisfied as of April 10, 2025.
- Lin receives standard non-employee director cash compensation (payable to KKR) but no equity grants.
- Letter agreement deletes Section 5.11 of the KKR Strategic Partnership Agreement, removing investor's voting commitment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000228/000119312525111677/0001193125-25-111677-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000228/000119312525111677/d71170d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-111677

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer